Medicare AdvantageCoverageMedium impact
MA14.001a, Electroconvulsive Therapy (ECT)
Independence Blue Cross·Psychiatry, Neurology, Anesthesiology·Medical Policy
Effective date
Jul 9, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA14.001a for Electroconvulsive Therapy (ECT) has been reissued with an effective date of July 9, 2025. This is a policy update that may contain changes to coverage criteria, prior authorization requirements, or billing guidelines for ECT procedures.
Action Required
By July 9, 2025: Billing and clinical teams must review the complete updated MA14.001a ECT policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards. Update internal protocols and billing procedures accordingly to ensure compliance with the revised policy.